Conflicts of interest on federal government vaccine panels have been declining to “historically low levels” in recent years, according to a new study, whose findings are likely to increase debate over a contentious issue pushed by Health and Human Services Secretary Robert F. Kennedy Jr. The rate of conflicts found among members of the Centers…
In a highly unusual move, a small biotech company has disclosed a rejection letter from the Food and Drug Administration in hopes of rallying support for regulatory approval of an ultra-rare disease drug. The step is part of a campaign being pursued by Stealth BioTherapeutics in light of its seesaw experience with the agency over…
FDA Approves Tonmya for Fibromyalgia We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is now approved. The Food and Drug Administration granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced…
FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Season two of the hospital drama “The Pitt” will include storylines that envision how Medicaid cuts in Republicans’ One Big Beautiful Bill will impact…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Normally I keep the intro to this newsletter light-hearted. But today I feel compelled to acknowledge the terror that CDC employees felt Friday when…
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
FDA Approves Ajovy® for Preventive Treatment of Episodic Migraine in Children Aged 6–17 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene therapy, and blood product regulation. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” Health and Human Services spokesperson Andrew Nixon told STAT on Saturday. STAT+ Exclusive…